Evolv Technologies Holdings, Inc. (EVLV) 2025 Annual Report: Key Highlights and Investor Insights

Company Overview

Evolv Technologies Holdings, Inc., a Delaware corporation headquartered in Waltham, MA, is a leading provider of advanced security screening solutions. The company’s products are distributed globally and are designed to enhance safety in venues such as educational institutions, healthcare facilities, sports arenas, tourist attractions, industrial workplaces, and government buildings.

Financial Performance and Shareholder Information

• Aggregate Market Value: As of June 30, 2025, Evolv’s common stock held by non-affiliates was valued at approximately \$999 million based on a closing price of \$6.24 per share.
• Shares Outstanding: As of March 3, 2026, the company had 179,350,739 shares of Class A common stock outstanding, with a par value of \$0.0001 per share.
• Public Float and Reporting Status: Evolv regained status as a current filer on April 28, 2025, but is not eligible to use Form S-3 registration statements until one year after regaining current filer status. This may affect the speed and cost of future capital raises.

Key Business Developments

• Restatement and Internal Control Material Weaknesses:

  Material weaknesses in internal controls led to previously disclosed restatements for financial periods in 2022, 2023, and early 2024. The company is actively working to remediate these weaknesses, but cannot guarantee success or that further issues will not arise. This exposes Evolv to potential regulatory action, litigation, loss of investor confidence, and possible delisting or financial penalties.

• Profitability:

  Evolv has a history of losses, reporting net losses of \$33.1 million in 2025 and \$54 million in 2024, with an accumulated deficit of \$387.8 million as of December 31, 2025. The company may not achieve or maintain profitability in the future, and expects costs to increase as it invests in R&D, sales and marketing, new product launches, and general administration.

• Headcount and Human Capital:

  As of December 31, 2025, Evolv employed 286 people, with headcount stable compared to 2024. On January 21, 2025, a Board-approved reduction in force affected 41 employees, aimed at improving profitability and cash flow.

• Product and Market Expansion:

  Evolv is focusing on developing initial customer successes in key metropolitan areas and expanding its global sales pipeline. The company is targeting verticals such as education, healthcare, sports, entertainment, theme parks, industrial workplaces, and municipal governments.

• Regulatory Compliance:

  The company is subject to extensive federal, state, and local regulations, including health and safety, anti-corruption, and export controls. Evolv reports material compliance with these laws but warns that failure to comply could result in fines, penalties, or adverse business impacts.

• Risks and Uncertainties:
  • Material weaknesses in internal controls and risk of further restatements.
  • Historical lack of profitability and uncertain path to sustained profits.
  • Potential for significant operating result fluctuations due to macroeconomic conditions, customer retention, pricing, and international market dynamics.
  • Dependency on reseller partners and third-party technologies.
  • Exposure to litigation, regulatory enforcement, and compliance risks.
  • Debt covenants may limit operating flexibility.
  • Volatility of share price and warrants.
  • Requirement for additional capital, which may not be readily available.

Shareholder Considerations & Price Sensitive Issues

• Restatement and Internal Controls: Ongoing remediation of material weaknesses in financial reporting, and the risk that unresolved issues could lead to regulatory action or further restatements, potentially affecting share value.
• Profitability Concerns: Continued losses and uncertain profitability could impact investor confidence and share price.
• Capital Raising Constraints: Temporary inability to use Form S-3 for capital raises may slow financing and increase transaction costs.
• Market Volatility: The company’s stock and warrants have been highly volatile and may continue to be so due to the above risks and uncertainties.
• Operational Risks: Significant risks related to customer retention, macroeconomic conditions, partner relationships, legal compliance, and expansion into international markets.

Forward-Looking Statements and Industry Data

Evolv’s report contains forward-looking statements regarding business strategy, financial position, operations, regulatory risks, and market expansion. These statements are subject to significant risks and uncertainties and should not be relied upon as guarantees of future performance.

Industry and market data are based on internal analysis and third-party sources, which may be imprecise or incomplete. Future results may differ materially from estimates and assumptions provided.

Additional Information

Investors can access additional information, including SEC filings, on Evolv’s Investor Relations website (https://ir.evolvtechnology.com) and the SEC’s website.

Disclaimer

This article is intended for informational purposes only and should not be construed as investment advice. The information contained herein is based on the company’s SEC filings and public disclosures as of the date specified. Investors should conduct their own research and consult with professional advisors before making investment decisions. The author and publisher are not responsible for any losses incurred as a result of reliance on this information.

View Evolv Technologies Holdings, Inc. Historical chart here